Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia
Adult T cell leukemia/lymphoma (ATL) is an aggressive cancer of CD4/CD25+ T lymphocytes, the etiological agent of which is human T-cell lymphotropic virus type 1 (HTLV-1). ATL is highly refractory to current therapies, making the development of new treatments a high priority. Oncolytic viruses such...
Main Authors: | Betancourt, Dillon, Ramos, Juan Carlos, Barber, Glen N. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Society for Microbiology
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645320/ |
Similar Items
-
Retargeting of Viruses to Generate Oncolytic Agents
by: Verheije, M. H., et al.
Published: (2012) -
Potent systemic therapy of Multiple Myeloma utilizing Oncolytic Vesicular stomatitis virus coding for Interferon-beta
by: Naik, Shruthi, et al.
Published: (2012) -
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer
by: Heiber, Joshua F., et al.
Published: (2011) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
by: Campadelli-Fiume, Gabriella, et al.
Published: (2016) -
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
by: Muik, Alexander, et al.
Published: (2012)